Holen Sie sich die Stockscreener-App
3.97
1.98%
-0.08
Handel nachbörslich:
3.97
Schlusskurs vom Vortag:
$4.05
Offen:
$3.99
24-Stunden-Volumen:
355.04K
Relative Volume:
0.64
Marktkapitalisierung:
$126.50M
Einnahmen:
$160.43M
Nettoeinkommen (Verlust:
$-227.64M
KGV:
-0.0577
EPS:
-68.77
Netto-Cashflow:
$-170.79M
1W Leistung:
-6.59%
1M Leistung:
-11.38%
6M Leistung:
+123.03%
1J Leistung:
-16.07%
1-Tages-Spanne:
$3.835
$3.99
1-Wochen-Bereich:
$3.835
$4.3977
52-Wochen-Spanne:
$1.38
$7.34
Agenus Inc Stock (AGEN) Company Profile
Firmenname
Agenus Inc
Sektor
Branche
Telefon
781-674-4410
Adresse
3 FORBES ROAD, LEXINGTON, MA
Vergleichen Sie AGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
3.97 | 129.05M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-09-28 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-04-22 | Eingeleitet | B. Riley FBR | Buy |
| 2016-10-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | Bestätigt | Maxim Group | Buy |
| 2016-03-11 | Hochstufung | Maxim Group | Hold → Buy |
| 2015-12-16 | Eingeleitet | Jefferies | Buy |
| 2015-10-27 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-07-27 | Bestätigt | MLV & Co | Buy |
| 2015-06-11 | Eingeleitet | Oppenheimer | Outperform |
| 2015-01-12 | Bestätigt | Maxim Group | Buy |
| 2015-01-09 | Bestätigt | MLV & Co | Buy |
| 2015-01-09 | Bestätigt | Maxim Group | Buy |
| 2014-12-19 | Bestätigt | Maxim Group | Buy |
| 2014-05-08 | Bestätigt | Maxim Group | Buy |
| 2014-03-14 | Bestätigt | MLV & Co | Buy |
| 2013-10-08 | Bestätigt | Maxim Group | Buy |
| 2012-01-05 | Eingeleitet | William Blair | Outperform |
| 2011-12-01 | Eingeleitet | Global Hunter Securities | Buy |
Alle ansehen
Agenus Inc Aktie (AGEN) Neueste Nachrichten
Is Agenus Inc. a candidate for recovery play2025 Retail Activity & Low Risk Entry Point Tips - newser.com
What is the fair value of Agenus Inc. stock nowJuly 2025 Rallies & Low Drawdown Trading Strategies - newser.com
Can Agenus Inc. stock resist sector downturns2025 Technical Overview & Fast Momentum Entry Tips - newser.com
Is Agenus Inc. (AJ8) stock trading at attractive multiplesJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com
Is Agenus Inc. stock bottoming outGDP Growth & Verified High Yield Trade Plans - newser.com
Why millennials buy Agenus Inc. (AJ8) stock2025 Key Highlights & Technical Pattern Based Signals - newser.com
What RSI levels show for Agenus Inc. (AJ8) stockJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
Will Agenus Inc. stock outperform value stocks2025 Top Gainers & Smart Investment Allocation Tips - newser.com
Heatmap analysis for Agenus Inc. and competitorsGold Moves & Verified Momentum Stock Alerts - newser.com
Is Agenus Inc. (AJ8) stock overpriced at current multiplesEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Applying Wyckoff theory to Agenus Inc. stockGold Moves & Verified Momentum Stock Alerts - newser.com
Custom strategy builders for tracking Agenus Inc.July 2025 PostEarnings & Community Consensus Trade Alerts - newser.com
Agenus Secures $10M Promissory Note with Zydus - TipRanks
Is Agenus Inc. showing signs of accumulationJuly 2025 PreEarnings & Intraday High Probability Alerts - newser.com
Is Agenus Inc. stock ready for a breakoutEarnings Beat & Community Supported Trade Ideas - newser.com
Agenus (NASDAQ:AGEN) Stock Price Passes Above 200-Day Moving AverageTime to Sell? - MarketBeat
Published on: 2025-10-07 01:11:05 - earlytimes.in
Agenus Inc Stock Analysis and ForecastInflation Impact on Stocks & Free Trading Signals to Sharpen Your Edge - earlytimes.in
Is Agenus Inc. (AJ8) stock in buy zone after pullbackMarket Trend Report & Smart Swing Trading Alerts - newser.com
How to use a screener to detect Agenus Inc. breakoutsShare Buyback & Detailed Earnings Play Alerts - newser.com
Risk adjusted return profile for Agenus Inc. analyzedGap Up & Safe Capital Allocation Plans - newser.com
Signal strength of Agenus Inc. stock in tech scannersPortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Agenus Inc. (NASDAQ:AGEN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Why Agenus Inc. (AJ8) stock benefits from AI revolutionJuly 2025 Gainers & Low Drawdown Investment Strategies - newser.com
What analysts say about Agenus Inc stockPrice Momentum Alerts & Get Free Training on Technical Indicators - earlytimes.in
What drives Agenus Inc AJ8 stock priceStock Buy Signals & Top Analyst Picks Available for Free - earlytimes.in
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone - Investing News Network
Strs Ohio Acquires Shares of 142,516 Agenus Inc. $AGEN - MarketBeat
Agenus (NASDAQ:AGEN) Stock Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Agenus and Zydus transactions face new CFIUS review, closing shifts to Q4 - Investing.com Nigeria
Agenus Faces CFIUS Review Delay in Zydus Deal - TipRanks
Agenus and Zydus transactions face new CFIUS review, closing shifts to Q4 By Investing.com - Investing.com South Africa
Finanzdaten der Agenus Inc-Aktie (AGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):